METHOD OF PROVIDED EFFICIENCY OF NON-ADJUVANT AUTOHEMOCHEMOTHERAPY FOR PATIENTS SUFFERING FROM PAGET-TYPE BREAST CANCER Russian patent published in 2008 - IPC G01N33/74 

FIELD: medicine; oncology.

SUBSTANCE: patient's blood is tested prior to and after radioimmunotherapy for contents of progesterone, estradiol, follicle- and lutein-stimulating hormones. Patients after treatment are diagnosed with increased progesterone amount from 1.50 to 4.7 nmole/l, reduced ratio of follicle-stimulating to lutein-stimulating hormones from 0.88 to 0.32 and reduced ratio of estradiol to progesterone from 208 to 117, and tumour regression is diagnosed with reduction of progesterone from 0.95-1.34 nmole/l to 0.41-0.83, increased ratio of follicle-stimulating to lutein-stimulating hormones from 0.83-3.81 to 2.07-4.41 and reduced ratio of estradiol to progesterone from 205.2-328.4 to 255.8-671.1.

EFFECT: method application allows detecting of autohemochemotherapy efficiency within postoperative period for patients suffering from Paget-type breast cancer, providing further therapy course correction.

1 tbl, 2 ex